GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SEEGENE Inc (XKRX:096530) » Definitions » Net Income (Continuing Operations)

SEEGENE (XKRX:096530) Net Income (Continuing Operations) : ₩29,782 Mil (TTM As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is SEEGENE Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. SEEGENE's Net Income (Continuing Operations) for the three months ended in Sep. 2024 was ₩1,744 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2024 was ₩29,782 Mil.

SEEGENE Net Income (Continuing Operations) Historical Data

The historical data trend for SEEGENE's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SEEGENE Net Income (Continuing Operations) Chart

SEEGENE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26,709.83 503,147.15 537,560.66 182,432.36 733.20

SEEGENE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4,680.16 5,959.43 -1,983.22 24,061.20 1,744.49

SEEGENE Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩29,782 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SEEGENE  (XKRX:096530) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

SEEGENE Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of SEEGENE's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

SEEGENE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SEEGENE Inc (XKRX:096530) » Definitions » Net Income (Continuing Operations)
Comparable Companies
XKRX:085660 XKRX:016790 XKRX:141080 XKRX:064550 XKRX:298380 XKRX:005250 XKRX:214450 XKRX:950160 XKRX:950210 XKRX:087010 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
Taewon Building 65-5 Bangyi-Dong, Songpa-gu, Seoul, KOR, 138-050
Website
http://www.seegene.co.kr
SEEGENE Inc is engaged in the healthcare sector. The Korean firm specializes in developing upgraded technology for accurate diagnosis of various diseases. Its products include pathogen inspection solutions such as respiratory, gastrointestinal, tuberculosis and meningitis pathogens.

SEEGENE Headlines

No Headlines